Nancy H. Covell, New York State Psychiatric Institute
On April 3, 2009, public testimony on comparative effectiveness
research was given at a meeting of the National Advisory Council
for Healthcare Research and Quality. The testimony represents
the views of the presenter and not necessarily those of the Agency
for Healthcare Research and Quality (AHRQ) or the Department
of Health and Human Services (HHS).
The Council provides advice and recommendations to the Director,
AHRQ, and to the Secretary, HHS, on priorities for a national
health services research agenda.
Delivered Via Electronic Mail
I am writing to note the need for comparative effectiveness studies targeting antipsychotic polypharmacy. This practice places enormous burden on state and other provider budgets while also exposing individuals to increased risk of side effects, yet there is little data to guide it's effectiveness compared to other alternatives. I am happy to see dollars set aside for such important research and look forward to reading the minutes from your public meeting.
Nancy H. Covell, Ph.D.
Research Project Director I
Department of Mental Health Services and Policy Research
New York State Psychiatric Institute
Associate Director of Research
CT DMHAS Research Division
410 Capitol Avenue, MS#14RSD
PO Box 341431
Hartford, CT 06134
Return to Contents